Your browser doesn't support javascript.
loading
A randomised, double-blind, placebo-controlled crossover trial of the influence of the HCN channel blocker ivabradine in a healthy volunteer pain model: an enriched population trial.
Lee, Michael C; Bond, Simon; Wheeler, Daniel; Scholtes, Ingrid; Armstrong, Graham; McNaughton, Peter; Menon, David.
Afiliação
  • Lee MC; Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Bond S; Cambridge Clinical Trials Unit, Cambridge University NHS Foundation Trust, Cambridge, United Kingdom.
  • Wheeler D; Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Scholtes I; Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • Armstrong G; Cambridge Clinical Trials Unit, Cambridge University NHS Foundation Trust, Cambridge, United Kingdom.
  • McNaughton P; Wolfson Centre for Age-Related Diseases, Kings College London, London, United Kingdom.
  • Menon D; Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
Pain ; 160(11): 2554-2565, 2019 11.
Article em En | MEDLINE | ID: mdl-31188268

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ivabradina / Hiperalgesia / Analgésicos / Neuralgia Tipo de estudo: Clinical_trials Idioma: En Revista: Pain Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ivabradina / Hiperalgesia / Analgésicos / Neuralgia Tipo de estudo: Clinical_trials Idioma: En Revista: Pain Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido